Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
<!-- Name:DistributionId Value:8803438 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Evoke Pharma
GIMOTI Receives Nomination for 2022 Healio Industry Breakthrough Award
GIMOTI recognized as a major disruptor in the gastroenterology field, including several large global pharmaceutical companies Vote for GIMOTI as 2022 Healio Industry Breakthrough Product…
Evoke Pharma and EVERSANA Expand Patient Access to GIMOTI® With New Telehealth…
SOLANA BEACH, Calif. and CHICAGO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company primarily focused on treatments for…
Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The…
Ranked #1 in IFFGD Virtual Walk to spread awareness and support research for gastrointestinal disorders Evoke attending ANMS 2022 meeting August 5-7 in Philadelphia, PA SOLANA…
Evoke Pharma Announces Approval of GIMOTI® to the Texas Medicaid Preferred Drug List
SOLANA BEACH, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI)…
Evoke Pharma to Report Fourth Quarter and Full Year 2021 Financial Results on March…
SOLANA BEACH, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases,…
Evoke Pharma and EVERSANA Announce Acceptance of Abstract for Poster of Distinction…
SOLANA BEACH, Calif., and CHICAGO, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for…
GIMOTI® Commercialization Update
New Research Study Demonstrates Increased Acceptance Among Healthcare Providers Patient Testimonial Videos Detail Benefits Included and Available on GimotiRx.com Expanded Coverage…